Strides Pharma Science delivered a remarkable financial performance in the March quarter, posting a net profit of Rs 85.61 crore—an impressive surge from Rs 10.44 crore in the same quarter last year. Revenue climbed 16.7% year-over-year to Rs 1,202.37 crore, driven primarily by strong traction in the US market. Despite an increase in expenses, the company outperformed its revenue guidance of 12-15%, closing FY25 with a 17.2% growth.

Accenture, the global IT powerhouse, is set to promote approximately 15,000 employees in India as part of its larger global initiative affecting nearly 50,000 staff worldwide this June. This move comes alongside a permanent shift in the company’s promotion cycle—from December to June—to better align with client budget cycles and market demand visibility. With India constituting a significant portion of Accenture’s workforce and growth engine, these promotions and base pay adjustments underscore the firm’s confidence in expanding IT spending.

Tata Motors projects a conservative low single-digit growth in passenger vehicle sales for the fiscal year 2025-26, aligning with industry expectations. The company is pinning its hopes on reviving its premium hatchback segment, particularly through the launch of the all-new Altroz, priced between Rs 6.89 lakh and Rs 11.29 lakh. Despite shelving plans for an electric Altroz due to market saturation in the Rs 8-15 lakh EV segment, Tata remains optimistic about growth in mid and premium hatchbacks.

In a strategic move to safeguard buyer confidence amid evolving trade negotiations, BMW Group India has introduced a price protection offer for customers purchasing the UK-imported MINI 3-Door Cooper S. The initiative comes as India and the United Kingdom finalize a landmark Free Trade Agreement (FTA) that is expected to reduce import duties on automobiles. Under the limited-time scheme, valid for 180 days, BMW pledges to refund any price difference if tariffs are lowered post-purchase.

In a bold reaffirmation of its commitment to India's North-East, the Adani Group has announced an additional Rs. 50,000 crore investment over the next decade, doubling down on its development agenda in the region. This new pledge, unveiled at the Rising NorthEast Investors Summit, builds on a previous Rs. 50,000 crore promise made in Assam earlier this year. Chairman Gautam Adani outlined a comprehensive strategy spanning green energy, digital infrastructure, roadways, and vocational training.

Reliance Industries Ltd. has announced an ambitious Rs. 75,000 crore investment plan aimed at transforming India’s North-East over the next five years. The initiative spans clean energy, telecom expansion, rural retail development, biogas production, and healthcare infrastructure. Chairman Mukesh Ambani revealed the roadmap at the Rising NorthEast Investors Summit, highlighting plans to build 350 biogas plants, a cancer hospital, FMCG units, and Olympic training centers across eight states.

Himachal Pradesh Chief Minister Sukhvinder Singh Sukhu has urged the Union Government to raise import duties on apples in response to rising imports from Turkey that are undercutting domestic producers. In a meeting with Finance Minister Nirmala Sitharaman, Sukhu emphasized the adverse impact on Himachal's apple economy and also sought fiscal support for the hill state. Key demands included an increase in the borrowing limit for special category states and greater financial flexibility.

Glance, the consumer tech firm backed by Google, has introduced a groundbreaking AI-native commerce platform designed to revolutionize how users shop online. The newly launched Glance AI leverages proprietary artificial intelligence to create hyper-personalized fashion experiences by allowing users to upload selfies and receive photorealistic try-ons tailored to their individual appearance.

India is poised to become the primary engine of global oil demand growth over the next decade, surpassing China, according to a recent report by Moody's Ratings. While China remains the world’s second-largest oil consumer, its demand is nearing a plateau due to slowing economic growth and rapid adoption of clean energy technologies. In contrast, India’s expanding industrial base, rising urbanization, and ambitious infrastructure projects are set to drive annual crude demand growth of 3–5% through 2030.

Lincoln Pharmaceuticals is steering into a new era of strategic growth, with a sharp focus on lifestyle and chronic care—particularly in women's health and dermatology. The Ahmedabad-based drugmaker reported a net profit of Rs. 11.62 crore for the March quarter of FY25, down from Rs. 18.8 crore in the same period last year, despite a year-over-year increase in revenue. The company aims to bolster its global footprint through product registrations for exports while maintaining a net debt-free status. A long-term goal to reach Rs.